Healthcare -
Biotechnology - NASDAQ - US
$ 9.75
0.619 %
$ 752 M
Market Cap
-3.18
P/E
REPL - CASH FROM FINANCING ACTIVITIES
Cash from Financing Activities REPL - Replimune Group, Inc.
16.3 M
LAST VALUE
57.09%
2 YEAR CAGR
-30.63%
5 YEAR CAGR
0.00%
10 YEAR CAGR